Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine,Pharmacology (medical)
Reference44 articles.
1. Åberg M, Nilsson IM, Vilhardt H. The release of fibrinolytic activator and factor VIII after injection of DDAVP. In Davidson JF (Ed.) Progress in chemical fibrinolysis and thrombolysis, pp. 92–97, Churchill Livingstone, London and New York, 1979
2. Aronson AS, Andersson KE, Bergstrand CG, Mulder JL. Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin. Acta Paediatrica Scandinavica 62: 133–140, 1973
3. Aronson AS, Svenningsen NW. DDAVP test for estimation of renal concentrating capacity in infants and children. Archives of Disease in Childhood 49: 654–659, 1974
4. Aunsholt NA, Vilhardt H, Schmidt EB. Plasma half-life of DDAVP in uraemic patients. Acta Pharmacologica et Toxicologica 59: 332–333, 1986
5. Becker DJ, Foley TP. The effect of water deprivation and water loading during treatment with 1-deamino-8-D-arginine vasopressin in central diabetes insipidus in childhood. Acta Endocrinologica 97: 358–360, 1981
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献